BLIN vs XBIO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 11, 2026
BLIN
XBIO
Investment Advisor Scores
XBIO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BLIN | XBIO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.1507 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 2.0% | 12.0% | XBIO |
| Earnings Growth | 12.5% | 0.0% | BLIN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.5/100 | 33.8/100 | BLIN |
| Profit Margin | -8.6% | -75.9% | BLIN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BLIN
MarkdownPrice below a falling SMA50 (slope -4.1%), weak momentum, RSI 27
XBIO
MarkupPrice above SMA50, rising 50-day trend (12.0% over 20 days), RSI 54
Fundamentals Snapshot
| Metric | BLIN | XBIO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.3 | -11.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.7% | 1.0% |
| Operating Margin | -0.1% | -1.5% |
| EPS | -0.10 | -1.15 |
| Dividend Yield | — | — |